Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones
- 1 October 2014
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 86, 797-805
Abstract
No abstract availableKeywords
Funding Information
- Center for Cancer Research
- US National Cancer Institute (Z01 BC006161)
This publication has 43 references indexed in Scilit:
- Recent advances in small organic molecules as DNA intercalating agents: Synthesis, activity, and modelingEuropean Journal of Medicinal Chemistry, 2014
- A New Target for an Old Drug: Identifying Mitoxantrone as a Nanomolar Inhibitor of PIM1 Kinase via Kinome-Wide Selectivity ModelingJournal of Medicinal Chemistry, 2013
- Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling PathwayACS Medicinal Chemistry Letters, 2013
- New Approaches of PARP-1 Inhibitors in Human Lung Cancer Cells and Cancer Stem-Like Cells by Some Selected Anthraquinone-Derived Small MoleculesPLOS ONE, 2013
- Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?Clinical and Translational Oncology, 2012
- G-Quadruplex Binding Ligands: from Naturally Occurring to Rationally Designed MoleculesCurrent Pharmaceutical Design, 2012
- New Strategies in the Discovery of Novel Non-Camptothecin Topoisomerase I InhibitorsCurrent Medicinal Chemistry, 2011
- Mitoxantrone Analogues as Ligands for a Stem−Loop Structure of Tau Pre-mRNAJournal of Medicinal Chemistry, 2009
- DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial InhibitionChemical Reviews, 2009
- Identification of novel protein kinase CK1 delta (CK1δ) inhibitors through structure-based virtual screeningBioorganic & Medicinal Chemistry Letters, 2008